Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
Nagaendran Kandiah,1,2 Ming-Chyi Pai,3,4 Vorapun Senanarong,5 Irene Looi,6,7 Encarnita Ampil,8 Kyung Won Park,9 Ananda Krishna Karanam,10 Stephen Christopher11 1Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, 2Duke-NUS, Graduate Medical School, Singapore; 3Division...
Guardado en:
Autores principales: | Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/740898df6938411badbc5c6c821ebf0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cerebral Hemodynamics and Carotid Atherosclerosis in Patients With Subcortical Ischemic Vascular Dementia
por: Xiao-Jiao Liu, et al.
Publicado: (2021) -
Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
por: Ruangritchankul S, et al.
Publicado: (2021) -
Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
por: Campbell NL, et al.
Publicado: (2015) -
The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
por: Tahereh Jamshidnejad-Tosaramandani, et al.
Publicado: (2021) -
The Psychiatric Misdiagnosis of Behavioral Variant Frontotemporal Dementia in a Colombian Sample
por: Lina Zapata-Restrepo, et al.
Publicado: (2021)